Bridgefront Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-997
Closed -$325K 697
2024
Q1
$325K Sell
997
-359
-26% -$88.1K 0.25% 160
2023
Q4
$258K Sell
1,356
-306
-18% -$57.8K 0.2% 209
2023
Q3
$331K Sell
1,662
-345
-17% -$81.6K 0.23% 175
2023
Q2
$573K Buy
+2,007
New +$557K 0.31% 104
2021
Q1
Sell
-2,649
Closed -$275K 966
2020
Q4
$275K Buy
+2,649
New +$229K 0.09% 404

Other funds holding SWAV

Bridgefront Capital's SWAV Position: Q2 2024 in Review

Bridgefront Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 997 shares — an estimated $325K sold.

Bridgefront Capital first reported a position in SWAV in Q4 2020 and held it in 5 quarters. The position peaked at $573K in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Bridgefront Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bridgefront Capital sold 997 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $325K.
  • Bridgefront Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Bridgefront Capital's Shockwave Medical, Inc. Common Stock position peaked at $573K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Bridgefront Capital's 13F filing for Q2 2024, filed 14 Aug 2024.